Skip to main content

Table 1 Characteristics of patients with initially proven and suspected invasive candidiasis

From: Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study

Patients’ characteristics

SAT for initially proven invasive candidiasis

N = 291

SAT for suspected invasive candidiasis

N = 544

P value

At ICU admission

   

 Age (years)

62.2 ± 15.4

61.9 ± 14.5

0.93

 Male gender

185 (63.6)

337 (62.0)

0.64

Reason for admission to ICU

 Medical

119 (40.9)

268 (49.3)

0.02

 Surgical

161 (55.3)

260 (47.8)

0.04

 Trauma

16 (5.5)

16 (2.9)

0.08

C-reactive protein (mg/L)

165.9 ± 109.4

173.1 ± 122.6

0.67

Creatinine (µmol/L)

145.8 ± 109.6

132.1 ± 96.9

0.13

Red blood cell transfusion in ICU

163 (56.0)

289 (53.1)

0.42

Platelet transfusion in ICU

60 (20.6)

119 (21.9)

0.67

At SAT initiation

 Length of hospital stay before SAT (days)

13 [6; 23]

11 [4; 20]

<0.01

 Length of ICU stay before SAT (days)

5 [2; 14]

4 [0; 11]

<0.01

 Body temperature (°C)

37.6 ± 1.3

37.7 ± 1.3

0.34

 SAPS II

46.2 ± 18.0

50.1 ± 18.7

0.006

 SOFA score

7.3 ± 4.8

8.3 ± 4.3

0.0007

 Septic shock

120 (41.2)

330 (66.7)

<0.0001

 Severe sepsis

118 (40.6)

203 (37.3)

0.36

Risk factors for invasive candidiasisa

 Invasive mechanical ventilation

196 (67.4)

458 (84.2)

<0.0001

 Central venous catheter

278 (95.5)

526 (96.7)

0.44

 Urinary catheterization

280 (96.2)

516 (94.9)

0.50

 Antibiotic treatment

268 (92.1)

481 (88.4)

0.12

 Total parenteral nutrition

149 (51.2)

235 (43.2)

0.03

 Hemodialysis or hemodiafiltration

92 (31.6)

160 (29.4)

0.51

 Corticosteroid treatment

55 (18.9)

151 (27.8)

0.005

Surgery just before or during ICU stay

197 (67.7)

341 (62.7)

0.15

 Abdominal surgery

156 (78.2)

263 (79.2)

0.80

 Scheduled abdominal surgery

16 (10.3)

48 (18.3)

0.03

 Emergency abdominal surgery

140 (89.7)

215 (81.7)

0.03

 Mortality on D28

96 (34.4 %)

163 (31.6 %)

0.42

  1. The results are given as n (%) or mean ± SD, when indicated
  2. SAT systemic antifungal therapy, ICU intensive care unit, SOFA sequential organ failure assessment; SAPS II: simplified acute physiology score
  3. aRisk factors as per IDSA and ESCMID guidelines (3, 4)